Oxidative and Nitrosative Stress in Major Depressive Disorder: A Case Control Study
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Introduction: The role of increased oxidative stress and alterations to the nitric oxide (NO) pathway have been implicated in major depressive disorder (MDD). The two pathways interact closely with each other but have not been studied simultaneously in MDD. This study aimed to assess and compare the levels of oxidative and nitrosative stress in the neutrophils (PMNs) of drug-naive MDD patients and their first-degree relatives. Methods: 29 drug-naive MDD patients and 27 healthy first-degree relatives and healthy controls aged 18–45 years were included in this study. An assessment of the levels of reactive oxygen species (ROS), nitrites, neuronal NO synthase (nNOS), and myeloperoxidase in PMNs, and cortisol in serum was carried out. Results: Compared to healthy controls, the generation of free radicals, myeloperoxidase activity, and nNOS mRNA expression in PMNs, and cortisol level in serum were significantly higher in drug-naive depression patients. Indeed, increased levels of myeloperoxidase and serum cortisol were also noted in first-degree relatives. The total nitrite content in the PMNs and plasma however was significantly lower in both patients and first-degree relatives. Interestingly, a positive correlation was established in the ROS levels in the PMNs, plasma and neutrophil nitrite, and the serum cortisol level between MDD patients and their first-degree relatives. Conclusion: The results of this study contribute towards a better understanding of the familial association of depressive disorder, and demonstrate for the first time that neutrophil ROS/RNS, plasma nitrite, and serum cortisol levels are positively correlated between MDD patients and their first-degree relatives. However, further studies in larger, more diverse samples are needed to extend these pathways as potential biomarkers to identify persons at high risk for psychopathology at an early stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced plasma levels of antioxidants (vitamin E, zinc, coenzyme Q10, glutathione) and enzymes (xanthine oxidase and superoxide dismutase) are interrelated with worsening depressive symptoms (102).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 8×
“HAM-D: 17-item Hamilton Depression Rating Scale, GAF: Global Assessment of Functioning Scale.”
MethodInfluentialMolecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 1×
“At the same time, it is also known that patients with depression have elevated levels of inflammatory markers [3,40,41].”
BackgroundGlutamate, nitric oxide and cell-cell signalling in the nervous system
Garthwaite, J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90022-m · Cited by 2,402 · cited 1×
“NO is also involved in the release of neurotransmitters (including dopamine), neural development, regeneration, the regulation of gene expression, and synaptic plasticity which is believed to be related to learning and memory [17].”
BackgroundBiosynthesis of nitric oxide from l-arginine
Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90403-6 · Cited by 1,208
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140 · cited 1×
“Consequent to increased reactive oxygen species (ROS) levels, depression is also related to depleted levels of antioxidants such as vitamin E, zinc, coenzyme Q10, and glutathione as well as the exhaustion of antioxidative enzyme activities such as xanthine oxidase and superoxide dismutase [4,5,9,10].”
BackgroundGawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594 · cited 1×
“Studies in post-mortem brain samples have further displayed increased levels of ROS including peroxide and superoxide and altered levels of antioxidant defenses in depression patients [13,14].”
BackgroundGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554 · cited 1×
“have also reported elevated levels of glucocorticoids in patients with MDD [71].”
BackgroundSarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486 · cited 2×
“The human brain is believed to be more vulnerable to oxidative stress compared to other organs and tissues in the body [8].”
BackgroundGlucocorticoids inhibit the induction of nitric oxide synthase in macrophages
Di Rosa, M., Radomski, M., Carnuccio, R., & Moncada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91583-e · Cited by 453 · cited 1×
“nNOS activity is also inhibited by glucocorticoids [37,72]; multiple mechanisms thus seem to be responsible for the regulation of nitric oxide synthesis and metabolism in MDD.”
BackgroundNitrate reduction by shaking with cadmiumAlternative to cadmium columns
JONES, M. (1984) · Water Research · doi:10.1016/0043-1354(84)90215-x · Cited by 374 · cited 1×
“Louis, MO, USA) were added to reduce nitrate to nitrite as described earlier [49] and an equal volume of Griess reagent (0.”
MethodAntioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368
Family Discord, Parental Depression, and Psychopathology in Offspring: Ten-Year Follow-up
NOMURA, Y., WICKRAMARATNE, P. J., WARNER, V., MUFSON, L., & WEISSMAN, M. M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200204000-00012 · Cited by 349 · cited 2×
“Parental depression predisposes a resilient risk factor in offspring [51], and Zalar et al.”
BackgroundHerken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322 · cited 2×
“showed no significant change in the level of plasma nitrite in patients with major depression [4].”
BackgroundNitrite in nitric oxide biology: Cause or consequence?
Bryan, N. S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.019 · Cited by 260
Elevated plasma nitrate levels in depressive states
Suzuki, E., Yagi, G., Nakaki, T., Kanba, S., & Asai, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00164-6 · Cited by 255 · cited 1×
“The major limitation of these studies was their small sample size and the inclusion of patients taking an antidepressant (imipramine, amitriptyline, or mianserin), sedative–hypnotic (nitrazepam or triazolam), and anti-anxiety (etizolam or tandospirone) drugs [67].”
BackgroundNitric oxide and major depression
Dhir, A., & Kulkarni, S. K. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.02.002 · Cited by 235 · cited 1×
“Nitric oxide modulates major neurotransmitters such as norepinephrine, serotonin, dopamine, and glutamate involved in the neurobiology of major depression [19].”
BackgroundBernstein, H.-G., Stanarius, A., Baumann, B., Henning, H., Krell, D., Danos, P., Falkai, P., & Bogerts, B. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00461-2 · Cited by 223 · cited 1×
“Several clinical studies in post-mortem brains have shown reduced nNOS expression in the hypothalamus and locus coeruleus of depression patients [68,69].”
BackgroundGałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205 · cited 1×
“Studies in post-mortem brain samples have further displayed increased levels of ROS including peroxide and superoxide and altered levels of antioxidant defenses in depression patients [13,14].”
BackgroundJoca, S. R. L., & Guimarães, F. S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0326-2 · Cited by 204
(1996) · PubMed · Cited by 194
Chrapko, W. E., Jurasz, P., Radomski, M. W., Lara, N., Archer, S. L., & Le Mellédo, J.-M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.003 · Cited by 193
Role of antioxidants in generalised anxiety disorder and depression
Gautam, M., Agrawal, M., Gautam, M., Sharma, P., Gautam, A., & Gautam, S. (2012) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.102424 · Cited by 188
Antioxidants as Antidepressants: Fact or Fiction?
Scapagnini, G., Davinelli, S., Drago, F., De Lorenzo, A., & Oriani, G. (2012) · CNS Drugs · doi:10.2165/11633190-000000000-00000 · Cited by 182
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165 · cited 3×
“Accordingly, antioxidant treatment has been shown to improve psychiatric symptoms in clinical trials [10].”
BackgroundHarkin, A., Connor, T. J., Burns, M. P., & Kelly, J. P. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.010 · Cited by 164
Wallerath, T., Gath, I., Aulitzky, W. E., Pollock, J. S., Kleinert, H., & Förstermann, U. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655925 · Cited by 157 · cited 1×
“Many pieces of evidence indicate that, similar to neurons, human neutrophils (PMNs) also express nNOS [30].”
BackgroundVaccarino, V., Brennan, M., Miller, A. H., Bremner, J. D., Ritchie, J., Lindau, F., Veledar, E., Su, S., Murrah, N. V., Jones, L., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.023 · Cited by 150 · cited 3×
“At the same time, it is also known that patients with depression have elevated levels of inflammatory markers [3,40,41].”
BackgroundKotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149
Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
Gałecki, P., Gałecka, E., Maes, M., Chamielec, M., Orzechowska, A., Bobińska, K., Lewiński, A., & Szemraj, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.016 · Cited by 141 · cited 3×
“, who demonstrated an elevated leukocytes MPO transcript and serum MPO protein in depressive patients [42,54].”
BackgroundDhir, A., & Kulkarni, S. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.028 · Cited by 133
The relationship between potency of oxidative stress and severity of depression
Yanik, M., Erel, O., & Kati, M. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.00090.x · Cited by 125 · cited 1×
“To date, most studies have focused on analyzing the oxidative stress in depression patients only and a positive correlation between oxidative stress and severity of depression has been reported [10,12].”
BackgroundOverexpression of Neutrophil Neuronal Nitric Oxide Synthase in Parkinson's Disease
Gatto, E. M., Galdo, N. A. R., Carreras, M. C., Cherñavsky, A. C., Rubio, A., Satz, M. L., & Poderoso, J. J. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0288 · Cited by 118 · cited 1×
“Several clinical studies have shown that an alteration in the nNOS–NO pathway in the human brain is also reflected in circulating neutrophils [32,33].”
BackgroundExpression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders
Oliveira, R. M. W., Guimarães, F. S., & Deakin, J. F. W. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008000400012 · Cited by 112
N-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis
Fernandes, B. S., Dean, O. M., Dodd, S., Malhi, G. S., & Berk, M. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15r09984 · Cited by 108
Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A. K., Nag, D., Srimal, R. C., Seth, P. K., & Dikshit, M. (2001) · Psychopharmacology · doi:10.1007/s002130100860 · Cited by 99
Self-citationN-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
Ooi, S. L., Green, R., & Pak, S. C. (2018) · BioMed Research International · doi:10.1155/2018/2469486 · Cited by 98
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A., Nag, D., Seth, P. K., Srimal, R. C., & Dikshit, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00421-9 · Cited by 85
Self-citationLow nNOS protein in the locus coeruleus in major depression
Karolewicz, B., Szebeni, K., Stockmeier, C. A., Konick, L., Overholser, J. C., Jurjus, G., Roth, B. L., & Ordway, G. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02792.x · Cited by 84 · cited 1×
“Several clinical studies in post-mortem brains have shown reduced nNOS expression in the hypothalamus and locus coeruleus of depression patients [68,69].”
BackgroundSun, M., Zhao, Y., Gu, Y., & Xu, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.017 · Cited by 76
Affective Disorders and Nitric Oxide: A Role in Pathways to Relapse and Refractoriness?
HARVEY, B. H. (1996) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199607)11:4<309::aid-hup775>3.0.co;2-b · Cited by 75
Jyoti, A., Singh, A. K., Dubey, M., Kumar, S., Saluja, R., Keshari, R. S., Verma, A., Chandra, T., Kumar, A., Bajpai, V. K., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4970 · Cited by 73
Self-citationHerken, H., Akyol, O., Yilmaz, H. R., Tutkun, H., Savas, H. A., Ozen, M. E., Kalenderoglu, A., & Gulec, M. (2006) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.742 · Cited by 69 · cited 1×
“Consequent to increased reactive oxygen species (ROS) levels, depression is also related to depleted levels of antioxidants such as vitamin E, zinc, coenzyme Q10, and glutathione as well as the exhaustion of antioxidative enzyme activities such as xanthine oxidase and superoxide dismutase [4,5,9,10].”
BackgroundModulation of Nitric-Oxide Synthase by Nicotine
Tonnessen, B. H., Severson, S. R., Hurt, R. D., & Miller, V. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38944-x · Cited by 67
Nitric oxide and biopterin in depression and stress
van Amsterdam, J., & Opperhuizen, A. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(98)00140-1 · Cited by 66 · cited 1×
“(1999) reported a significant correlation between neopterin and biopterin (N:B) ratios and the severity of depression [22].”
BackgroundGałecki, P., Maes, M. H. J., Florkowski, A., Lewiñski, A., Gałecka, E., Bieńkiewicz, M., & Szemraj, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.005 · Cited by 63 · cited 1×
“Interestingly, Galecki and colleagues following a large study of depressive patients demonstrated an association between nNOS/iNOS gene polymorphism and increased disease susceptibility [70].”
BackgroundSethi, S., Singh, M. P., & Dikshit, M. (1999) · Blood · doi:10.1182/blood.v93.1.333 · Cited by 61
Self-citationGlobal arginine bioavailability ratio is decreased in patients with major depressive disorder
Ali-Sisto, T., Tolmunen, T., Viinamäki, H. T., Mäntyselkä, P. T., Valkonen‐Korhonen, M., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Ruusunen, A. A., Nandania, J., Velagapudi, V., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.030 · Cited by 61 · cited 1×
“evaluated the NO metabolism in patients of MDD and demonstrated lower levels of arginine as well as a lower global arginine bioavailability ratio (GABR) in the serum of MDD patients [63].”
BackgroundO'Connor, K. J., & Moncada, S. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90040-g · Cited by 57 · cited 1×
“nNOS activity is also inhibited by glucocorticoids [37,72]; multiple mechanisms thus seem to be responsible for the regulation of nitric oxide synthesis and metabolism in MDD.”
BackgroundUmathe, S., Bhutada, P., Jain, N. S., Mundhada, Y. R., Borkar, S., & Dhumal, B. (2009) · Nitric oxide · doi:10.1016/j.niox.2009.07.001 · Cited by 56
Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine
Seth, P., Kumari, R., Dikshit, M., & Srimal, R. (1994) · Blood · doi:10.1182/blood.v84.8.2741.2741 · Cited by 55
Self-citationRibaudo, G., Bortoli, M., Pavan, C., Zagotto, G., & Orian, L. (2020) · Antioxidants · doi:10.3390/antiox9080714 · Cited by 50
Caruso, G., Grasso, M., Fidilio, A., Torrisi, S. A., Musso, N., Geraci, F., Tropea, M. R., Privitera, A., Tascedda, F., Puzzo, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.809541 · Cited by 49 · cited 1×
“Indeed, conventional antidepressant medications including doxepin, fluoxetine, and vortioxetine endowed with oxidative and nitrosative scavenging activities have a protective effect [62].”
BackgroundPolymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients
Barthwal, M. K., Srivastava, N., Shukla, R., Nag, D., Seth, P. K., Srirnal, R. C., & Dikshit, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00400.x · Cited by 47 · cited 1×
“Several clinical studies have shown that an alteration in the nNOS–NO pathway in the human brain is also reflected in circulating neutrophils [32,33].”
BackgroundSelf-citationPlasma Nitrate Levels and Flow-Mediated Vasodilation in Untreated Major Depression
García, R. G., Zarruk, J. G., Barrera, C., Pinzón, A., Trillos, E., Arenas, W. D., Luengas, C., Tomaz, C., & López-Jaramillo, P. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31821566cf · Cited by 43
Myeloperoxidase gene expression and cognitive functions in depression
Talarowska, M. E., Szemraj, J., & Gałecki, P. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.06.001 · Cited by 41 · cited 1×
“, who demonstrated an elevated leukocytes MPO transcript and serum MPO protein in depressive patients [42,54].”
BackgroundSingh, A. K., Awasthi, D., Dubey, M., Nagarkoti, S., Kumar, A., Chandra, T., Barthwal, M. K., Tripathi, A. K., & Dikshit, M. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.06.002 · Cited by 34 · cited 4×
“β-Actin was used as an internal standard to calculate the relative mRNA expression [47,50].”
BackgroundMethodInfluentialSelf-citationAntioxidant vitamin intakes and risk of depression, anxiety and stress among female adolescents
Farhadnejad, H., Tehrani, A. N., Salehpour, A., & Hekmatdoost, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.09.010 · Cited by 31
Zalar, B., Blatnik, A., Maver, A., Klemenc–Ketiš, Z., & Peterlin, B. (2018) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2018-0010 · Cited by 29 · cited 1×
“have shown that the genetic make-up of MDD patients with a positive family history of depression is different from sporadic cases [52].”
BackgroundPlasma nitrite/nitrate concentrations in patients with schizophrenia
Djordjevic, V., Stojanović, I. R., Stankovic-Ferlez, D., Ristić, T., Lazarevic, D. S., Ćosić, V., & Djordjević, V. B. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.014 · Cited by 26
Loeb, E., Asmar, K. E., Trabado, S., Gressier, F., Colle, R., Rigal, A., Martin, S., Verstuyft, C., Fève, B., Chanson, P., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720001749 · Cited by 26 · cited 3×
“Importantly, NOS activity increases significantly over time after antidepressant treatment, and the inhibition of NOS isoforms led to antidepressant-like effects in mice [42,66].”
BackgroundDietary nitrate: poison or panacea?
Vallance, P. J. (1997) · Gut · doi:10.1136/gut.40.2.288 · Cited by 16
Frank, M. G., Hendricks, S. E., Bessette, D., Johnson, D. R., Wieseler Frank, J. L., & Burke, W. J. (2001) · Neuropsychobiology · doi:10.1159/000054906 · Cited by 11 · cited 2×
“has shown elevated ROS generation by the monocytes of depressive patients and linked their role with inflammation [53].”
BackgroundGlobal Assessment Functioning Scale
Peter, H., Penzel, T., Peter, J. H., & Peter, J. G. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_300739 · Cited by 10
Galkina, S. I., Golenkina, E. A., Fedorova, N. V., Ksenofontov, A. L., Serebryakova, M. V., Arifulin, E. A., Stadnichuk, V. I., Baratova, L. A., & Sud’ina, G. F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709719 · Cited by 9 · cited 1×
“The infiltration of neutrophils in the CNS contributes to the development of numerous neurodegenerative disorders, including MDD [31].”
BackgroundSingh, A. K., Awasthi, D., Dubey, M., Nagarkoti, S., Chandra, T., Barthwal, M. K., Tripathi, A. K., & Dikshit, M. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1a0820-514r · Cited by 5 · cited 3×
“β-Actin was used as an internal standard to calculate the relative mRNA expression [47,50].”
MethodSelf-citation
Research works printed but not linked: 1
- Sadock B. Sadock V. Ruiz P. Depression and Bipolar Disorder. Kaplan & Sadock’s Synopsis of Psychiatry 11th ed. Wolters Kluwer Philadelphia, PA, USA 2015 752 830
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Reduced plasma levels of antioxidants (vitamin E, zinc, coenzyme Q10, glutathione) and enzymes (xanthine oxidase and superoxide dismutase) are interrelated with worsening depressive symptoms (102).”
BackgroundMolecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
Winiarska‐Mieczan, A., Kwiecień, M., Jachimowicz-Rogowska, K., Donaldson, J., Tomaszewska, E., & Baranowska‐Wójcik, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032258 · Cited by 155
Almulla, A. F., Thipakorn, Y., Vasupanrajit, A., Tunvirachaisakul, C., Oxenkrug, G., Al-Hakeim, H. K., & Maes, M. (2022) · Cells · doi:10.3390/cells11193112 · Cited by 31
Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
Anderson, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010350 · Cited by 33
Metadata
- Authors
- Somani, A., Singh, A. K., Gupta, B., Nagarkoti, S., Dalal, P. K., & Dikshit, M.
- Affiliations
- King George's Medical University (IN)
- Central Drug Research Institute (IN)
- Department of Psychiatry, King George’s Medical University, Lucknow 226003, India
- Corresponding author
- Dikshit, Madhu
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-21
- Volume
- 12
- Issue
- 2
- Pages
- 144
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC8870258
- OpenAlex
- W4206995814
- Cited by
- 54
- References
- 69
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 13 · 2023: 5 · 2022: 12
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Council of Scientific and Industrial Research, India
- University Grants Commission
- Central Drug Research Institute
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- major depressive disorder, oxidative stress, nitrosative stress, nitric oxide pathway, neutrophils, reactive oxygen species, myeloperoxidase, neuronal nitric oxide synthase, plasma nitrite, serum cortisol, first-degree relatives, biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.